Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
QTX3034
i
Other names:
QTX3034
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Quanta Therap
Drug class:
KRAS G12D inhibitor, KRAS inhibitor
Related drugs:
‹
MRTX1133 (8)
KS-58 (3)
RMC-9805 (2)
QTX3046 (1)
YL-17231 (1)
HRS-4642 (0)
KRAS Mutated Antigen-specific TCR-T Cell Therapy (0)
MRTX1257 (4)
AZD4785 (1)
AZ’8037 (1)
JAB-3312 (1)
ATG-012 (0)
ELI-002 7P (0)
JNJ-74699157 (0)
LY3499446 (0)
SLATE-KRAS (0)
Undisclosed KRAS peptide vaccine (0)
Undisclosed KRAS-loder (0)
Undisclosed MSC-derived Exosomes with KrasG12D siRNA (0)
Undisclosed anti-KRAS G12D mTCR PBL (0)
Undisclosed mDC3/8-KRAS vaccine (0)
mRNA-5671 (0)
MRTX1133 (8)
KS-58 (3)
RMC-9805 (2)
QTX3046 (1)
YL-17231 (1)
HRS-4642 (0)
KRAS Mutated Antigen-specific TCR-T Cell Therapy (0)
MRTX1257 (4)
AZD4785 (1)
AZ’8037 (1)
JAB-3312 (1)
ATG-012 (0)
ELI-002 7P (0)
JNJ-74699157 (0)
LY3499446 (0)
SLATE-KRAS (0)
Undisclosed KRAS peptide vaccine (0)
Undisclosed KRAS-loder (0)
Undisclosed MSC-derived Exosomes with KrasG12D siRNA (0)
Undisclosed anti-KRAS G12D mTCR PBL (0)
Undisclosed mDC3/8-KRAS vaccine (0)
mRNA-5671 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
KRAS G12V
Solid Tumor
KRAS G12V
Solid Tumor
QTX3034
Sensitive: D – Preclinical
QTX3034
Sensitive
:
D
QTX3034
Sensitive: D – Preclinical
QTX3034
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login